USPTO serial 86854470
Serial No. 86854470
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 8, 2019
- Examiner
- STEIN, JAMES W
- Law office
- Historical data usage
What this means
Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.
Need help with Serial No. 86854470?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Irvine, CA, US
IRVINE, CA, US
Irvine, CA, US
Irvine, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Steven J. Nataupsky
Steven J. Nataupsky KNOBBE, MATENS, OLSON & BEAR, LLP2040 MAIN STREET, 14TH FLOORIRVINE, CA 92614United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Computer software for collecting, storing and managing data and images for use by physicians and health care professionals to create medical treatment plans and medical devices and apparatus for patients | ACTIVE | — |
| 010 | Medical apparatus and instruments for treating cardiovascular disease or cardiovascular disorders; Medical devices, namely, endovascular balloon catheters, devices for the treatment of aneurysms, AAA stent grafts and stent grafts for treating aneurysms and vascular disease or disorders; Fitted stent covers and sleeves made from textiles and/or woven fabric; polymer closure devices, namely, abdominal aortic aneurysm (AAA) stent grafts and stent grafts used in the treatment of vascular and cardiovascular disease or cardiovascular disorders; medical polymers for use as a closure device, namely, abdominal aortic aneurysm (AAA) stent grafts and stent grafts; medical polymers in the nature of closure devices for treating vascular aneurysms, namely, abdominal aortic aneurysm (AAA) stent grafts and stent grafts; medical devices for treating vascular aneurysms; medical apparatus and instruments for treating vascular disease; stent delivery systems; stents; synthetic stent grafts; artificial vascular grafts; catheters and parts and fittings therefor; medical devices, namely, minimally invasive devices for aortic disease repair; medical introducers; medical devices for use in vascular and cardiovascular procedures, namely, catheters, wires, syringes, injection devices; Endovascular stent-grafts, endovascular stents, endovascular grafts and catheter delivery systems, consisting primarily of one or more long tubes, intended for use in the treatment of abdominal aortic aneurysms; Medical devices, all for the treatment of vascular disease, namely, stents, synthetic endovascular grafts, vascular prostheses, synthetic abdominal stent grafts, vascular implants comprising artificial material; vascular implant delivery systems comprised of catheters, valves, sheaths, handles and chassis; and accessories for the aforesaid goods, namely, introducer sheaths, curable polymeric implant fill material, implant fill material mixing devices, implant fill material injectors and implant fill material syringes; vascular implant delivery systems comprised of catheters, valves, sheaths, handles and chassis; and accessories for the aforesaid goods, namely, introducer sheaths, curable polymeric implant fill material, implant fill material mixing devices, implant fill material injectors and implant fill material syringes; Medical devices, namely, endovascular balloons | ACTIVE | — |
| 042 | Scientific research for medical purposes in the field of cardiovascular disease or cardiovascular disorders; educational services, namely, providing clinical evidence in the nature of clinical research information, and medical and scientific research information regarding medical procedures; providing online, non-downloadable software enabling physicians and health care professionals to collaborate in connection with medical records, images and information to treat patients; providing temporary use of on-line non-downloadable software for collecting, storing and managing data and images for use by physicians and health care professionals to create medical treatment plans and select medical devices and apparatus for patients; providing online, non-downloadable software for collecting, storing and managing data and images for use by physicians and health care professionals to create medical treatment plans and select medical devices and apparatus for patients | ACTIVE | — |
| 044 | Providing medical information on medical treatments, medical procedures and medical devices and apparatuses for physicians and health care professionals; providing medical information to educate physicians, health care professionals and patients on medical treatments, devices and apparatus | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Endologix, Inc.
- Other trademarks owned by ENDOLOGIX LLC
- Other trademarks owned by Endologix, Inc.
- Other trademarks owned by Endologix, Inc.
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 27, 2026 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Jun 27, 2026 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Jun 1, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 10, 2026 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Oct 8, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Oct 21, 2020 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Oct 8, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 4, 2019 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Sep 3, 2019 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Aug 2, 2019 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jul 26, 2019 | IUAF | USE AMENDMENT FILED | — |
| Jul 26, 2019 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Feb 5, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 4, 2019 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Feb 4, 2019 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jan 25, 2019 | EXT5 | SOU EXTENSION 5 FILED | — |
| Jan 25, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 27, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 25, 2018 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Jul 25, 2018 | EXT4 | SOU EXTENSION 4 FILED | — |
| Jul 25, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 27, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 25, 2018 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jan 25, 2018 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jan 25, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 27, 2017 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 25, 2017 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jul 25, 2017 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jul 25, 2017 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 27, 2017 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 25, 2017 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jan 25, 2017 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jan 25, 2017 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 26, 2016 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 31, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 31, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 11, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 13, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 13, 2016 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 13, 2016 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 13, 2016 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 13, 2016 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 5, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 30, 2015 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Dec 29, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 22, 2015 | NWAP | NEW APPLICATION ENTERED | — |